A Cure for Ethan

  • Description
  • FAQ
  • Comments
  • Supporters

Ethan is 14. He has MECP2 Duplication Syndrome and Lennox Gastault. The seizures started in 2016 and his mobility and health began to decline. You would never guess the struggles he has because he is the sweetest, happiest young man. Even when he feels terrible, he will try to smile. He's such a ladies man and loves to flirt. Everyone loves him and his sweet gentle nature.

The research on MECP2 Duplication Syndrome is especially promising. Treatments, and maybe even a cure, are possible with continued research progress. But this research needs funding. I’m doing this campaign to ask for your support. Every dollar you contribute goes directly to research on MECP2 Duplication Syndrome and could help find a cure for Ethan and others who struggle with this disorder.

Thank you very much.

What is MECP2 Duplication Syndrome?

Unlike Rett Syndrome, which is caused by mutations or deletions in the MECP2 gene, the symptoms that arise from the duplication syndrome are caused, as the name suggests, by having an area of the X chromosome (Xq28), which includes the MECP2 gene, erroneously duplicated. The section duplicated may vary from individual to individual and may also contribute to the severity of the disease.
The syndrome has been diagnosed mostly in boys. The majority inherits the duplication from their mothers who are typically asymptomatic due to favorable X chromosome inactivation (the moms have inactivated the X chromosome that harbors the duplication). Carrier mothers have a 50% chance of passing on the duplication to their children, meaning MECP2 Duplication Syndrome may be quite prevalent.

Learn more about MECP2 Duplication here.

What is the MECP2 Duplication Syndrome Fund at RSRT?

In an effort to immediately leverage RSRT's deep knowledge base and well established global scientific networks the MECP2 Duplication Syndrome Fund at RSRT was created in late 2010. The Fund puts the intellectual and scientific resources of RSRT immediately to work for the MECP2 Duplication/Triplication Syndrome community.
The Fund exclusively supports projects devoted to the study and means of treatment of MECP2 Duplication Syndrome. 100% of every dollar contributed is invested in research - not a single penny goes to overhead.
In 2012, a parent-driven effort was established to raise funds for the initial reversal experiments conducted at the Baylor College of Medicine. Families pledged to raise $401 to cover the cost of the experiments. The initiative was a success, and the 401 Project was born. All funds raised through the 401 Project initiative are directly deposited into the MECP2 Duplication Syndrome Fund at RSRT.

Learn more about RSRT here.

Supporters (0)

Nobody has supported this campaign yet. You can be the first!

This is a unique website which will require a more modern browser to work!

Please upgrade today!